Blog
RSS FeedPosted by Michael Wonder on 31 Aug 2025
FDA approval of Leqembi subcutaneous formulation charts path to combination therapies for Alzheimer's disease
29 August 2025 - Subcutaneous delivery increases accessibility and introduces potential for at home administration, following model of diabetes and ...
Posted by Michael Wonder on 27 Nov 2021
Shingrix approved in Canada for adults at increased risk of shingles due to immunodeficiency or immunosuppression
25 November 2021 - GlaxoSmithKline today announced that Shingrix (Zoster Vaccine Recombinant, Adjuvanted) has been approved in Canada for the prevention ...
Posted by Michael Wonder on 26 Nov 2021
Drug, insulin price caps head for showdown over Senate rules
26 November 2021 - Senate Democrats expect to defend key portions of their drug pricing agenda against a technical challenge ...
Posted by Michael Wonder on 26 Nov 2021
Additional insights from the agenda for the March 2022 PBAC meeting
26 November 2021 - More insights from the MAESTrO Team. ...
Posted by Michael Wonder on 26 Nov 2021
European Commission approves Byannli (6 monthly paliperidone palmitate) for the maintenance treatment of schizophrenia in adults
23 November 2021 - The approval is based on results from the Route 6 Study, which showed that 92.5 percent ...
Posted by Michael Wonder on 26 Nov 2021
Blackrock Neurotech's MoveAgain brain computer interface system receives breakthrough device designation from the FDA
16 November 2021 - Blackrock Neurotech today announces that the U.S. FDA has granted breakthrough device designation for its groundbreaking ...
Posted by Michael Wonder on 26 Nov 2021
Johnson & Johnson COVID-19 vaccine fully approved by Health Canada to prevent COVID-19 in individuals 18 years and older
24 November 2021 - Vaccine demonstrates protection against COVID-19 related hospitalisation and death, and across different variants. ...
Posted by Michael Wonder on 26 Nov 2021
Health Canada issues Notice of Compliance for Trodelvy, a new treatment option for an aggressive type of metastatic breast cancer
25 November 2021 - Trodelvy significantly reduced the risk of death by 49% compared with single agent chemotherapy in the ...
Posted by Michael Wonder on 26 Nov 2021
Health Canada approves Wegovy for the treatment of adults with obesity
25 November 2021 - Novo Nordisk announced today that Health Canada has approved Wegovy (semaglutide injection), the first-and-only prescription weight-loss medication ...
Posted by Michael Wonder on 25 Nov 2021
Insights from the agenda (version 1.0) for the March 2022 PBAC meeting
26 November 2021 - Some insights from the MAESTrO Team. ...
Posted by Michael Wonder on 25 Nov 2021
PHARMAC publishes minutes of August 2021 PTAC meeting
25 November 2021 - Another sparse meeting in terms of the number of new funding applications and funding applications for ...
Posted by Michael Wonder on 25 Nov 2021
Preparing for health care’s new frontier: Committee releases major report on reforming the process for new medicines and health technology
25 November 2021 - A new parliamentary report ‘The New Frontier: Delivering better health for all Australians’ is recommending significant ...
Posted by Michael Wonder on 25 Nov 2021
Tagrisso, Opdivo fail to get broader reimbursement
25 November 2021 - AstraZeneca Korea’s non-small-cell lung cancer treatment Tagrisso (osimertinib) and Ono Pharma Korea’s immunotherapy Opdivo (nivolumab) failed ...
Posted by Michael Wonder on 25 Nov 2021
Health funds not meeting expectations
25 November 2021 - Quarterly private health insurance data from the Australian Prudential Regulation Authority reveal that health funds have ...
Posted by Michael Wonder on 25 Nov 2021
Comirnaty COVID-19 vaccine: EMA recommends approval for children aged 5 to 11
25 November 2021 - EMA’s CHMP has recommended granting an extension of indication for the COVID-19 vaccine Comirnaty to include use ...
Posted by Michael Wonder on 25 Nov 2021
Drugmakers gear up for price restrictions in Biden’s legislative agenda
25 November 2021 - Industry potentially faces significant expansion of government regulation despite success in watering down Democratic proposals. ...